Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,205 | 71,734 | 120,614 | 96,938 | 100,808 |
| Receivables | 132,241 | 110,414 | 118,145 | 114,916 | 118,129 |
| Inventories | 211,429 | 189,133 | 206,919 | 171,806 | 171,261 |
| Income taxes - deferred | N/A | 30,564 | 48,616 | 39,100 | 36,155 |
| Other current assets | 0 | 99,785 | 0 | 0 | 0 |
| TOTAL | $438,495 | $529,321 | $521,152 | $453,051 | $452,257 |
| Non-Current Assets | |||||
| PPE Net | 205,181 | 193,626 | 200,310 | 177,898 | 131,383 |
| Intangibles | 1,116,129 | 776,047 | 446,927 | 506,334 | 530,102 |
| Other Non-Current Assets | 14,419 | 88,425 | 23,750 | 26,316 | 30,367 |
| TOTAL | $1,335,729 | $1,058,098 | $670,987 | $710,548 | $691,852 |
| Total Assets | $1,774,224 | $1,587,419 | $1,192,139 | $1,163,599 | $1,144,109 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,772 | 28,867 | 50,752 | 36,742 | 27,656 |
| Accrued Expenses | 84,314 | 74,452 | 64,433 | 66,682 | 69,669 |
| TOTAL | $139,127 | $126,025 | $119,382 | $106,929 | $101,868 |
| Non-Current Liabilities | |||||
| Long Term Debt | 481,875 | 413,125 | 186,875 | 321,875 | 179,688 |
| Deferred Revenues | 5,666 | 5,176 | 4,197 | 3,505 | 4,543 |
| Other Non-Current Liabilities | 246,888 | 243,530 | 217,709 | 211,627 | 364,189 |
| TOTAL | $883,654 | $757,072 | $406,667 | $538,895 | $549,603 |
| Total Liabilities | $1,022,781 | $883,097 | $526,049 | $645,824 | $651,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,001 | 65,557 | 64,826 | 55,978 | 53,760 |
| Common Shares | 917 | 416 | 410 | 369 | 357 |
| Retained earnings | 145,879 | 314,960 | 280,956 | 302,023 | 260,819 |
| Other shareholders' equity | -48,023 | -23,609 | 806 | -4,918 | -9,214 |
| TOTAL | $751,443 | $704,322 | $666,090 | $517,775 | $492,638 |
| Total Liabilities And Equity | $1,774,224 | $1,587,419 | $1,192,139 | $1,163,599 | $1,144,109 |